HOYA Corporation

7741.T
Medical Instruments & Supplies
2026/04/14 Updated
Market Cap: $61.5B (¥9.8T)
Stock Price: $182.60 (¥29,170)
Exchange Rate: 1 USD = ¥159.74

(Change) Notice Regarding Change of Effective Date for Company Split (Simplified Absorption-type Split) Concerning the Endoscopy Business

The effective date of the company split for the endoscopy business has been changed from May 1, 2026 to August 1, 2026. The change is due to delays in administrative procedures, with no impact on consolidated financial results.

Importance:
Page Updated: March 26, 2026
IR Disclosure Date: March 26, 2026

Key Figures

  • Effective Date (After Change): August 1, 2026 (Scheduled)
  • Effective Date (Before Change): May 1, 2026 (Scheduled)
  • Impact on Consolidated Financial Results: None

AI要約

Regarding Change of Effective Date for Company Split

HOYA Corporation has decided to change the effective date of the simplified absorption-type split concerning its endoscopy business, announced on July 10, 2025, from the originally planned May 1, 2026 to August 1, 2026. The endoscopy business is scheduled to be transferred through the absorption-type split to the newly established wholly owned subsidiary, PENTAX Medical LLC, which is expected to become a wholly owned subsidiary of HOYA Holdings N.V. The reason for the change is that the administrative procedures in various countries are taking longer than anticipated.

Future Outlook and Impact

It is stated that the change of the effective date will not affect consolidated financial results. The decision by the Representative Executive Officer to change the effective date and the contract conclusion were made on March 26, 2026. Procedures will continue as scheduled toward the spin-off. While the delay in the business split is noted for investors, the important point is that there is no financial impact.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.